Skip to content

Phensuximide

NERVOUS SYSTEM

Also known as: fensuccimide, phensuccimide, phensuximid, racemic phensuximide, RS-Phensuximide, succitimal

OfmFDA approvedATC N03AD02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Phensuximide is an ofm drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including CACNA1G|CACNA1H|CACNA1I. Recorded indications include Absence seizure and Epilepsy.

  • Approval status: ofm.
  • Molecular targets: CACNA1G|CACNA1H|CACNA1I (1 listed in DrugCentral).
  • Indications: Absence seizure and Epilepsy.
  • ATC code: N03AD02 (Succinimide derivatives).
  • Molecular formula: C11H11NO2; molecular weight 189.21 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Absence seizure
  • Epilepsy

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Voltage-gated T-type calcium channelCACNA1G|CACNA1H|CACNA1Iblocker—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA—PARKE DAVIS

ATC classification

ATC codeTherapeutic hierarchy
N03AD02NERVOUS SYSTEM › ANTIEPILEPTICS › ANTIEPILEPTICS › Succinimide derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Phensuximide is on its molecule page.

Molecular formulaC11H11NO2
Molecular weight189.21 g/mol
CAS number86-34-0
InChIKeyWLWFNJKHKGIJNW-UHFFFAOYSA-N
PubChem CID6839
CN1C(=O)CC(C1=O)C1=CC=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Phensuximide used for?

DrugCentral lists the following indications for Phensuximide: Absence seizure and Epilepsy.

How does Phensuximide work?

Its molecular targets in DrugCentral include CACNA1G|CACNA1H|CACNA1I (blocker).

What is the chemical formula of Phensuximide?

Phensuximide has the molecular formula C11H11NO2 and a molecular weight of 189.21 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval—
AgencyFDA
Targets1
Indications2
FormulaC11H11NO2
DrugCentral ID2139
Interactive profile